June 16, 2023
Saying the case has long been over, a Patent Trial and Appeal Board official has rejected requests that Arthrex Inc. filed nearly two years ago seeking to have the director of the patent office review a 2017 decision invalidating claims of a suture patent.
August 17, 2021
In the wake of the U.S. Supreme Court's Arthrex decision, the U.S. Patent and Trademark Office director has been asked by Arthrex Inc. itself to review a 2017 ruling invalidating two claims in a suture patent that were canceled by the USPTO in June.